Skip to main content
SpringerLink
Log in

Malignant Soft Tissue Tumors in Children

  • Chapter
  • First Online:
Skin Tumors and Reactions to Cancer Therapy in Children

  • 444 Accesses

Abstract

Malignant soft tissue tumors represent a diverse group of diagnoses. They are classified into two main groups—rhabdomyosarcomas and non-rhabdomyosarcomas. Non-rhabdomyosarcomas are further differentiated based on their tissue of origin. Most soft tissue tumors present as growing subcutaneous masses, but several have distinct cutaneous findings. In all cases, a biopsy is required to make an accurate diagnosis. Ongoing advances in molecular diagnostics allow for more precise classification and diagnosis. Complete surgical excision, when possible, is the treatment of choice for most soft tissue tumors. Additional treatments and prognosis are tumor dependent and vary by patient age. Herein we provide a unique review of the pediatric soft tissue malignancies with special attention given to their cutaneous manifestations and clinical mimics. Histopathology and imaging characteristics, as well as prognosis, are also discussed. General treatment suggestions are included, but multispecialty care lead by a pediatric oncologist with expertise in this area is necessary to implement a suitable treatment plan.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Williams RF, Fernandez-Pineda I, Gosain A. Pediatric Sarcomas. Surg Clin N Am. 2016;96(5):1107–25.

    Article  PubMed  Google Scholar 

  2. Thacker MM. Malignant soft tissue tumors in children. Orthopedic Clin North Am. 2013;44(4):657–67.

    Article  Google Scholar 

  3. Gurney JG, Severson RK, Davis S, et al. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer. 1995;75(8):2186–95.

    Article  CAS  PubMed  Google Scholar 

  4. Ognjanovic S, Carozza SE, Chow EJ, et al. Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype. Br J Cancer. 2010;102(1):227–31.

    Article  CAS  PubMed  Google Scholar 

  5. Crucis A, Richer W, Brugières L, et al. Rhabdomyosarcomas in children with neurofibromatosis type I: a national historical cohort. Pediatr Blood Cancer. 2015;62(10):173.

    Article  CAS  Google Scholar 

  6. Christman MP, Kerner JK, Cheng C, et al. Rhabdomyosarcoma arising in a giant congenital melanocytic nevus. Pediatr Dermatol. 2014;31(5):584–7.

    Article  PubMed  Google Scholar 

  7. Malempati S, Hawkins DS. Rhabdomyosarcoma: review of the Children’s oncology group (COG) soft-tissue sarcoma committee experience and rationale for current COG studies. Pediatr Blood Cancer. 2012;59:5–10.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Shern JF, Chen L, Chmielecki J, et al. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov. 2014;4(2):216–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ognjanovic S, Linabery AM, Charbonneau B, et al. Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005. Cancer. 2009;115(18):4218–26.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Parham DM, Ellison DA. Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med. 2006;130(10):1454–65.

    PubMed  Google Scholar 

  11. Hettmer S, Archer NM, Somers GR, et al. Anaplastic Rhabdomyosarcoma in TP53 Germline mutation carriers. Cancer. 2014;120:1068–75.

    Article  CAS  PubMed  Google Scholar 

  12. Williamson D, Missiaglia E, de Reynies A, Pierron G, Thuille B, Palenzuela G, et al. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol. 2010;28:2151–8.

    Article  PubMed  Google Scholar 

  13. Cobanoglu B, Kandi B, Okur I. Primary cutaneous rhabdomyosarcoma in an adult. Dermatol Surg. 2009;35:1573.

    Article  CAS  PubMed  Google Scholar 

  14. Marburger TB, Gardner JM, Prieto VG, Billings SD. Primary cutaneous rhabdomyosarcoma: a clinicopathologic review of 11 cases. J Cutan Pathol. 2012;39:987–95.

    Article  PubMed  Google Scholar 

  15. Miser JS, Pappo AS, Triche TJ, et al. Other soft tissue sarcomas of childhood. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. PA, USA: Lippincott Williams & Wilkins; 2002. p. 1017–50.

    Google Scholar 

  16. Ferrari A, Casanova M. New concepts for the treatment of pediatric nonrhabdomyosarcoma soft tissue sarcomas. Expert Rev Anticancer Ther. 2005;5(2):307. Expanded Academic ASAP. Web. 31 Aug. 2016

    Article  CAS  PubMed  Google Scholar 

  17. Spunt SL, Hill DA, Motosue AM, et al. Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma. J Clin Oncol. 2002;20:3225–35.

    Article  PubMed  Google Scholar 

  18. Spunt SL, Poquette CA, Hurt YS, et al. Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children’s research hospital. J Clin Oncol. 1999;17:3697–705.

    Article  CAS  PubMed  Google Scholar 

  19. Pappo AS, Rao BN, Jenkins JJ, et al. Metastatic nonrhabdomyosarcomatous soft tissue sarcomas in children and adolescents: the St. Jude Children’s research hospital experience. Med Pediatr Oncol. 1999;33:76–82.

    Article  CAS  PubMed  Google Scholar 

  20. Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16(1):197–203.

    Article  CAS  PubMed  Google Scholar 

  21. Bates JE, Peterson CR, Dhakal S, et al. Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population. Pediatr Blood Cancer. 2014;61(11):1955–60.

    Article  PubMed  Google Scholar 

  22. Waxweiler TV, Proper MS, Rusthoven C, et al. Nonrhabdomyosarcoma soft tissue sarcomas in children: a surveillance, epidemiology, and end results analysis. Int J Radiat Oncol Biol Phys. 2013;87:S71.

    Article  Google Scholar 

  23. Cecchetto G, Carli M, Alaggio R, Dall'Igna P, Bisogno G, Scarzello G, et al. Fibrosarcoma in pediatric patients: results of the Italian cooperative group studies (1979–1995). J Surg Oncol. 2001;78(4):225–31.

    Article  CAS  PubMed  Google Scholar 

  24. Coffin CM. Congenital-infantile Fibrosarcoma: a comparison with adult-type fibrosarcoma. In: Coffin CM, Dehner LP, O'Shea PA, editors. Pediatric soft tissue tumors. A clinical, pathological, and therapeutic approach. Baltimore: Lippincott; 1997. p. 164–70.

    Google Scholar 

  25. Hayward PG, Orgill DP, Mulliken JB, et al. Congenital fibrosarcoma masquerading as lymphatic malformation: report of two cases. J Pediatr Surg. 1995;30(1):84–8.

    Article  CAS  PubMed  Google Scholar 

  26. Yan AC, Chamlin SL, Liang MG, et al. Congenital infantile fibrosarcoma: a masquerader of ulcerated hemangioma. Pediatr Dermatol. 2006;23(4):330–4.

    Article  PubMed  Google Scholar 

  27. Boon LM, Fishman SJ, Lund DP, et al. Congenital fibrosarcoma masquerading as congenital hemangioma: report of two cases. J Pediatr Surg. 1995;30:1378–81.

    Article  CAS  PubMed  Google Scholar 

  28. Asgari M, Rubin BP, Hornung RL. Neonate with a fibrosarcoma and consumptive coagulopathy. J Am Acad Dermatol. 2004;50:S23–5.

    Article  PubMed  Google Scholar 

  29. Muzaffar AR, Friedrich JB, Lu KK, et al. Infantile fibrosarcoma of the hand associated with coagulopathy. Plast Reconstr Surg. 2006;117(5):81e–6e.

    Article  PubMed  CAS  Google Scholar 

  30. Bourgeois JM, Knezevich SR, Mathers JA, Sorenson PH. Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors. Am J Surg Pathol. 2000;24:937–46.

    Article  CAS  PubMed  Google Scholar 

  31. Schofield DE, Fletcher JA, Grier HE, et al. Fibrosarcoma in infants and children: application of new techniques. Am J Surg Pathol. 1994;18(1):14–24.

    Article  CAS  PubMed  Google Scholar 

  32. Kimura C, Kitamura T, Sugihara T. A case of congenital infantile fibrosarcoma of the right hand. J Dermatol. 1998;25:735–41.

    Article  CAS  PubMed  Google Scholar 

  33. Sheng WQ, Hisaoka M, Okamoto S, et al. Congenital infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues. Am J Clin Pathol. 2001;115:348–55.

    Article  CAS  PubMed  Google Scholar 

  34. Knezevich SR, Garnett MJ, Pysher TJ, et al. ETV6-NTRK3 gene fusions and trisomy 11 establish a histo-genetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res. 1998;58:5046–8.

    CAS  PubMed  Google Scholar 

  35. Loh ML, Ahn P, Perez-Atayde AR, et al. Treatment of infantile fibrosarcoma with chemotherapy and surgery: results from the Dana-Farber Cancer Institute and Children's hospital. Boston J Pediatr Hematol Oncol. 2002;24(9):722–6.

    Article  PubMed  Google Scholar 

  36. Orbach D, Rey A, Cecchetto G, et al. Infantile fibrosarcoma: management based on the European experience. J Clin Oncol. 2010;28(2):318–23.

    Article  PubMed  Google Scholar 

  37. Coffin CM, Jaszcz W, O'Shea PA, et al. So-called congenital-infantile fibrosarcoma: does it exist and what is it? Pediatr Pathol. 1994;14(1):133–50.

    Article  CAS  PubMed  Google Scholar 

  38. Surico G, Muggeo P, Daniele RM, et al. Chemotherapy alone for the treatment of congenital fibrosarcoma: is surgery always needed? Med Pediatr Oncol. 2003;40:268–70.

    Article  PubMed  Google Scholar 

  39. Madden NP, Spicer RD, Allibone EB, et al. Spontaneous regression of neonatal fibrosarcoma. Br J Cancer. 1992;18:S72–5.

    CAS  Google Scholar 

  40. Alaggio R, Ninfo V, Rosolen A, et al. Primitive myxoid mesenchymal tumor of infancy: a clinicopathologic report of 6 cases. Am J Surg Pathol. 2006;30:388–94.

    Article  PubMed  Google Scholar 

  41. Nagasubramanian R, Wei J, Gordon P, et al. Infantile Fibrosarcoma with NTRK3–ETV6 fusion successfully treated with the Tropomyosin-related kinase inhibitor LOXO-101. Pediatr Blood Cancer. 2016;63(8):1468–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Manganoni AM, Pavoni L, Gualdi G, et al. Dermatofibrosarcoma protuberans in an adolescent: a case report and review of the literature. J Pediatr Hematol Oncol. 2013;35(5):383–7.

    Article  PubMed  Google Scholar 

  43. Hsi ED, Nickoloff BJ. Dermatofibroma and dermatofibrosarcoma protuberans: an immunohistochemical study reveals distinctive antigenic profiles. J Dermatol Sci. 1996;11(1):1–9.

    Article  CAS  PubMed  Google Scholar 

  44. Bouyssou-Gauthier ML, Labrousse F, Longis B, et al. Dermatofibrosarcoma protuberans in childhood. Pediatr Dermatol. 1997;14(6):463–5.

    Article  CAS  PubMed  Google Scholar 

  45. McKee PH, Fletcher CD. Dermatofibrosarcoma protuberans presenting in infancy and childhood. J Cutan Pathol. 1991;18(4):241–6.

    Article  CAS  PubMed  Google Scholar 

  46. Taylor HB, Helwig EB. Dermatofibrosarcoma protuberans. A study of 115 cases. Cancer. 1962;15(4):717–25.

    Article  CAS  PubMed  Google Scholar 

  47. Checketts SR, Hamilton TK, Baughman RD. Congenital and childhood dermatofibrosarcoma protuberans: a case report and review of the literature. J Am Acad Dermatol. 2000;42(5):907–13.

    Article  CAS  PubMed  Google Scholar 

  48. Kesserwan C, Sokolic R, Cowen EW, et al. Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase–deficient severe combined immune deficiency. J Allergy Clin Immunol. 2012;129(3):762–9.

    Article  CAS  PubMed  Google Scholar 

  49. Lee DW, Yang JH, Won CH, et al. A case of congenital pigmented dermatofibrosarcoma protuberans (Bednar tumor) in a patient with Fanconi anemia. Pediatr Dermatol. 2011;28(5):583–5.

    Article  PubMed  Google Scholar 

  50. Sack JE, Kuchnir L, Demierre MF. Dermatofibrosarcoma Protuberans arising in the context of Shwachman-diamond syndrome. Pediatr Dermatol. 2011;28(5):568–9.

    Article  PubMed  Google Scholar 

  51. Smith EH, Lan TT, Jo VY, et al. Dermatofibrosarcoma Protuberans in a patient with Cowden syndrome: revisiting the PTEN and PDGF pathways. Am J Dermatopathol. 2016;38(4):e40–3.

    Article  PubMed  Google Scholar 

  52. Rubocki RJ, Parsa JR, Hershfield MS, et al. Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency. Blood. 2001;97:809–11.

    Article  CAS  PubMed  Google Scholar 

  53. Nelson R, Shmalo J, Williams D, Hershfield M. Longterm survival and pegylated adenosine deaminase (ADA) therapy in a patient with ADA deficiency. Clin Immunol. 2006;119(suppl):S138.

    Article  Google Scholar 

  54. Martin L, Combemale P, Dupin M, et al. The atrophic variant of dermatofibrosarcoma protuberans in childhood: a report of six cases. Br J Dermatol. 1998;139:719–25.

    Article  CAS  PubMed  Google Scholar 

  55. Jafarian F, McCuaig C, Kokta V, et al. Dermatofibrosarcoma protuberans in childhood and adolescence: report of eight patients. Pediat Dermatol. 2008;25:317–25.

    Article  Google Scholar 

  56. Pedeutour F, Simon MP, Minoletti F, et al. Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement. Cytogenet Cell Genet. 1996;3:171–4.

    Article  Google Scholar 

  57. Gooskens SL, Oranje AP, Van Adrichem LN, et al. Imatinib mesylate for children with dermatofibrosarcoma protuberans (DFSP). Pediatr Blood Cancer. 2010;55:369–73.

    Article  PubMed  Google Scholar 

  58. Keshen TH, Cederna PS, Savell VH Jr, et al. Clinical and pathological features of pediatric dermatofibrosarcoma protuberans. Ann Plast Surg. 1995;35:633–7.

    Article  CAS  PubMed  Google Scholar 

  59. Pappo AS, Rao BN, Cain A, et al. Dermatofibrosarcoma protuberans: the pediatric experience at St. Jude children’s research hospital. Pediatr Hematol Oncol. 1997;14:563–8.

    Article  CAS  PubMed  Google Scholar 

  60. Goldberg DJ, Maso M. Dermatofibrosarcoma protuberans in a 9-year-old child: treatment by MOHS micrographic surgery. Pediatr Dermatol. 1990;7:57–9.

    Article  CAS  PubMed  Google Scholar 

  61. Malerich P, Pride H, Marks V, et al. Congenital dermatofibrosarcomaprotuberans treated with Mohs micrographic surgery. J Am Acad Dermatol. 2007;56:AB157.

    Google Scholar 

  62. Love WE, Keiler SA, Tamburro JE, et al. Surgical management of congenital dermatofibrosarcoma protuberans. J Am Acad Dermatol. 2009;61:1014–23.

    Article  PubMed  Google Scholar 

  63. Lindner NJ, Scarborough MT, Powell GJ, et al. Revision surgery in dermatofibrosarcoma protuberans of the trunk and extremities. Eur J Surg Oncol. 1999;25:392–7.

    Article  CAS  PubMed  Google Scholar 

  64. Thornton SL, Reid J, Papay FA, Vidimos AT. Childhood dermatofibrosarcoma protuberans: role of preoperative imaging. J Am Acad Dermatol. 2005;53(1):76–83.

    Article  PubMed  Google Scholar 

  65. Athale UH, Patil PS, Chintu C, et al. Influence of HIV epidemic on the incidence of Kaposi's sarcoma in Zambian children. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:96–100.

    Article  CAS  PubMed  Google Scholar 

  66. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med. 2000;342(14):1027–38.

    Article  CAS  PubMed  Google Scholar 

  67. Stefan DC. Patterns of distribution of childhood cancer in Africa. J Trop Pediatr. 2015;61:165–73.

    Article  PubMed  Google Scholar 

  68. Jackson CC, Dickson MA, Sadjadi M, et al. Kaposi sarcoma of childhood: inborn or acquired immunodeficiency to oncogenic HHV-8. Pediatr Blood Cancer. 2016;63(3):392–7.

    Article  CAS  PubMed  Google Scholar 

  69. Celtik C, Unuvar A, Aydogan A, et al. Human herpes virus type 8-associated Kaposi sarcoma in a pediatric liver transplant recipient. Pediatr Transplant. 2011;15:E100–4.

    Article  PubMed  Google Scholar 

  70. Abbas AA, Jastaniah WA. Extensive gingival and respiratory tract Kaposi sarcoma in a child after allogenic hematopoietic stem cell transplantation. J Pediatr Hematol Oncol. 2012;34:e53–5.

    Article  PubMed  Google Scholar 

  71. Sala I, Faraci M, Magnano GM, et al. HHV-8-related visceral Kaposi's sarcoma following allogeneic HSCT: report of a pediatric case and literature review. Pediatr Transplant. 2011;1(15):E8–11.

    Article  Google Scholar 

  72. Sahin G, Palanduz A, Aydogan G, et al. Classic Kaposi sarcoma in 3 unrelated Turkish children born to consanguineous kindreds. Pediatrics. 2010;125(3):e704–8.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Chagaluka G, Stanley C, Banda K, et al. Kaposi's sarcoma in children: an open randomised trial of vincristine, oral etoposide and a combination of vincristine and bleomycin. Eur J Cancer. 2014;50:1472–81.

    Article  CAS  PubMed  Google Scholar 

  74. Ziegler JL, Katongole-Mbidde E. Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer. 1996;65(2):200–3.

    Article  CAS  PubMed  Google Scholar 

  75. Restrepo CS, Martínez S, Lemos JA, et al. Imaging manifestations of Kaposi sarcoma 1. Radiographics. 2006;26(4):1169–85.

    Article  PubMed  Google Scholar 

  76. Pantanowitz L, Otis CN, Dezube BJ. Immunohistochemistry in Kaposi’s sarcoma. Clin Exp Dermatol. 2010;35:68–72.

    Article  CAS  PubMed  Google Scholar 

  77. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266:1865–9.

    Article  CAS  PubMed  Google Scholar 

  78. Mesri EA, Cesarman E, Boshoff C. Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer. 2010;10:707–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Roy D, Sin SH, Lucas A, et al. mTOR inhibitors block Kaposi sarcoma growth by inhibiting essential autocrine growth factors and tumor angiogenesis. Cancer Res. 2013;73(7):2235–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Anglemyer A, Agrawal AK, Rutherford GW. Treatment of Kaposi sarcoma in children with HIV-1 infection. Cochrane Database Syst Rev. 2014;1:CD009826.

    Google Scholar 

  81. Merimsky O, Jiveliouk I, Sagi-Eisenberg R. Targeting mTOR in HIV-negative classic Kaposi's sarcoma. Sarcoma. 2008;2008:825093.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Croteau S, Liang M, Kozakewich H, et al. Kaposiform Hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr. 2013;162(1):142–7.

    Article  PubMed  Google Scholar 

  83. Croteau SE, Gupta D. The clinical spectrumof kaposiform hemangioendothelioma and tufted angioma. Semin Cutan Med Surg. 2016;35(3):147–52.

    Article  PubMed  Google Scholar 

  84. el Dessouky M, Azmy AF, Raine PA, et al. Kasabach-Merritt syndrome. J Pediatr Surg. 1988;23:109–11.

    Article  PubMed  Google Scholar 

  85. Drolet B, Trenor C, Brandau L, et al. Consensus-derived practice standards plan for complicated Kaposiform Hemangioendothelioma. J Pediatr. 2013;163(1):285–91.

    Article  PubMed  Google Scholar 

  86. Adams D, Trenor C, Hammill A, et al. Efficacy and safety of oral sirolimus in the treatment of complicated vascular anomalies. Pediatrics. 2016;137(2):e20153257.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Oza VS, Mamlouk MD, Hess CP, Mathes EF, Frieden IJ. Role of Sirolimus in advanced Kaposiform Hemangioendothelioma. Pediatr Dermatol. 2016;33(2):e88–92.

    Article  PubMed  Google Scholar 

  88. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors. WHO Classification of Tumours of the Central Nervous System. Lyon: International Agency for Research on Cancer; 2007.

    Google Scholar 

  89. Rodriguez FJ, Folpe AL, Giannini C, et al. Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems. Acta Neuropathol. 2012;123(3):295–319.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Enzinger FM, Weiss SW. Malignant tumours of peripheral nerves. In: Enzinger FM, Weiss SW, editors. Soft tissue tumors, vol. 31. St. Louis: CV Mosby Company; 2001. p. 1209–63.

    Google Scholar 

  91. Casanova M, Ferrari A, Spreafico F, et al. Malignant peripheral nerve sheath tumors in children: a single-institution twenty-year experience. J Pediatr Hematol Oncol. 1999;21:509–13.

    Article  CAS  PubMed  Google Scholar 

  92. De Raedt T, Brems H, Wolkenstein P, et al. Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet. 2003;72:1288–92.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Perrone F, Tabano S, Colombo F, et al. p15INK4b, p14ARF and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumours. Clin Cancer Res. 2003;9:4132–8.

    CAS  PubMed  Google Scholar 

  94. Evans DG, Baser ME, McGaughran J, et al. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet. 2002;39:311–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Ferner RE, Lucas JD, O’Doherty MJ, et al. Evaluation of 18fluorodeoxyglucose positron emission tomography in the detection of malignant peripheral nerve sheath tumors in neurofibromatosis 1. J Neurol Neurosurg Psychiatry. 2000;68:353–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Anghileri M, Miceli R, Fiore M. Malignant peripheral nerve sheath tumors. Cancer. 2006;107(5):1065–74.

    Article  PubMed  Google Scholar 

  97. Friedrich RE, Hartmann M, Mautner VF. Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children. Anticancer Res. 2007;27(4A):1957–60.

    CAS  PubMed  Google Scholar 

  98. McCarville MB. What MRI can tell us about neurogenic tumors and rhabdomyosarcoma. Pediatr Radiol. 2016;46(6):881–90.

    Article  PubMed  Google Scholar 

  99. Calonje JE, Brenn T, Lazar A, McKee P, editors. McKee’s pathology of the skin. 4th ed. New York: Elsevier; 2011.

    Google Scholar 

  100. Matsumine A, Kusuzaki K, Nakamura T, et al. Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI. J Cancer Res Clin Oncol. 2009;135:891–900.

    Article  PubMed  Google Scholar 

  101. Santoro A, Tursz T, Mouridsen H, et al. Doxorubicin versus CY VADIC verses doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the EORTC soft tissue and bone sarcoma. J Clin Oncol. 1995;13:1537–45.

    Article  CAS  PubMed  Google Scholar 

  102. Serrano C, Simonetti S, Hernandez-Losa J, et al. BRAF V600E and KRAS G12S mutations in peripheral nerve sheath tumors. Histopathology. 2013;62:499–504.

    Article  PubMed  Google Scholar 

  103. Serrano C, Simonetti S, Hernandez J, et al. BRAF V600E mutations in benign and malignant nerve sheath tumors [abstract]. J Clin Oncol. 2010;28(Suppl 15):Abstract 10043.

    Article  Google Scholar 

  104. Kaplan HG. Vemurafenib treatment of BRAF V600E-mutated malignant peripheral nerve sheath tumor. J Nat Comprehensive Cancer Network. 2013;11(12):1466–70.

    Article  CAS  Google Scholar 

  105. Gurney JG, Young JL, Roffers SD, Smith MA, Bunin GR. Soft tissue sarcomas. In: LAG R, Smith MA, Gurney JG, et al., editors. Cancer incidence and survival among children and adolescents: United States SEER program 1975–1995. Bethesda, Md, USA: National Cancer Institute, SEER Program; 1999. p. 111–24.

    Google Scholar 

  106. Stanelle EJ, Christison-Lagay ER, Sidebotham EL, Singer S, Antonescu CR, Meyers PA, La Quaglia MP. Prognostic factors and survival in pediatric and adolescent liposarcoma. Sarcoma. 2012;5:2012.

    Google Scholar 

  107. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumors: results from the first National Wilms’ tumor study. Cancer. 1978;41(5):1937–48.

    Article  CAS  PubMed  Google Scholar 

  108. Tomlinson GE, Breslow NE, Dome J, et al. Rhabdoid tumor of the kidney in the National Wilms’ tumor study: age at diagnosis as a prognostic factor. J Clin Oncol. 2005;23(30):7641–5.

    Article  PubMed  Google Scholar 

  109. Chi SN, Zimmerman MA, Yao X, et al. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol. 2009;27(3):385–9.

    Article  PubMed  PubMed Central  Google Scholar 

  110. Weiss SW, Goldblum J. Malignant soft tissue tumors of uncertain type. In: Weiss SW, Goldblum JR, editors. Enzinger and Weiss's soft tissue tumors. St. Louis: CV Mosby; 2001. p. 1483–571.

    Google Scholar 

  111. Ferrari A, Gronchi A, Casanova M, et al. Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution. Cancer. 2004;101(3):627–34.

    Article  PubMed  Google Scholar 

  112. Raney RB. Synovial sarcoma in young people: background, prognostic factors, and therapeutic questions. J Pediatr Hematol Oncol. 2005;27(4):207–11.

    Article  PubMed  Google Scholar 

  113. Siegel HJ, Sessions W, Casillas MA, et al. Synovial sarcoma: clinicopathologic features, treatment, and prognosis. Orthopedics. 2007;30(12):1020.

    PubMed  Google Scholar 

  114. Andrassy RJ, Okcu MF, Despa S, et al. Synovial sarcoma in children: surgical lessons from a single institution and review of the literature. J Am Coll Surg. 2001;192:305–13.

    Article  CAS  PubMed  Google Scholar 

  115. Sessions WM, Siegel HJ, Casillas MA. Pit-falls in the diagnosis and management of synovial sarcoma. In: The Mid-America Ortho-paedic Association Proceedings. 2004. La Quinta, CA.

    Google Scholar 

  116. Brodsky JT, Burt ME, Hajdu SI, et al. Tendosynovial sarcoma: Clinicopathologic features, treatment, and prognosis. Cancer. 1992;70:484–9.

    Article  CAS  PubMed  Google Scholar 

  117. Eilber FC, Dry SM. Diagnosis and management of synovial sarcoma. J Surg Oncol. 2008;97:314–20.

    Article  PubMed  Google Scholar 

  118. Bakri A, Shinagare AB, Krajewski KM, et al. Synovial sarcoma: imaging features of common and uncommon primary sites, metastatic patterns, and treatment response. Am J Roentgenol. 2012;199(2):W208–15.

    Article  Google Scholar 

  119. Lisle JW, Eary JF, O’Sullivan J, et al. Risk assessment based on FDG-PET imaging in patients with synovial sarcoma. Clin Orthop Relat Res. 2008;467:1605–11.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Singer S, Baldini EH, Demetri GD, Fletcher JA, Corson JM. Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J Clin Oncol. 1996;14:1201–8.

    Article  CAS  PubMed  Google Scholar 

Recommended Reading

  • Croteau SE, Liang MG, Kozakewich HP, Alomari AI, Fishman SJ, Mulliken JB, Trenor CC. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr. 2013;162(1):142–7.

    Article  PubMed  Google Scholar 

  • Gurney JG, Young JL, Roffers SD, Smith MA, Bunin GR. Soft tissue sarcomas. In: LAG R, Smith MA, Gurney JG, et al., editors. Cancer incidence and survival among children and adolescents: United States SEER program 1975–1995. Bethesda, Md, USA: National Cancer Institute, SEER Program; 1999. p. 111–24.

    Google Scholar 

  • Ognjanovic S, Carozza SE, Chow EJ, Fox EE, Horel S, McLaughlin CC, et al. Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype. Br J Cancer. 2010;102(1):227–31.

    Article  CAS  PubMed  Google Scholar 

  • Pappo AS, Rao BN, Cain A, Bodner S, Pratt CB. Dermatofibrosarcoma protuberans: the pediatric experience at St. Jude children’s research hospital. Pediatr Hematol Oncol. 1997;14:563–8.

    Article  CAS  PubMed  Google Scholar 

  • Rudzinski ER, Anderson JR, Hawkins DS, Skapek SX, Parham DM, Teot LA. The World Health Organization classification of skeletal muscle tumors in pediatric rhabdomyosarcoma: a report from the Children’s oncology group. Arch Pathol Lab Med. 2015;139(10):1281–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Shern JF, Chen L, Chmielecki J, Wei JS, Patidar R, Rosenberg M, et al. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov. 2014;4(2):216–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Spunt SL, Poquette CA, Hurt YS, Cain AM, Rao BN, Merchant TE, et al. Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children’s research hospital. J Clin Oncol. 1999;17:3697–705.

    Article  CAS  PubMed  Google Scholar 

  • Thacker MM. Malignant soft tissue tumors in children. Orthop Clin N Am. 2013;44(4):657–67.

    Article  Google Scholar 

  • Williams RF, Fernandez-Pineda I, Gosain A. Pediatric Sarcomas. Surg Clin N Am. 2016;96(5):1107–25.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Dermatology, Department of Dermatology, University of Minnesota, 516 Delaware Street, SE, Mail Code 98, Phillips-Wangensteen Bldg., Suite 4-240, Minneapolis, MN, 55455, USA

    Christina L. Boull M.D. & Sheilagh M. Maguiness M.D.

Authors
  1. Christina L. Boull M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sheilagh M. Maguiness M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christina L. Boull M.D. .

Editor information

Editors and Affiliations

  1. Harvard Medical School, Boston Children’s Hospital, Boston, Massachusetts, USA

    Jennifer T. Huang

  2. Washington University School of Medicine, St. Louis, Missouri, USA

    Carrie C. Coughlin

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Boull, C.L., Maguiness, S.M. (2018). Malignant Soft Tissue Tumors in Children. In: Huang, J., Coughlin, C. (eds) Skin Tumors and Reactions to Cancer Therapy in Children. Springer, Cham. https://doi.org/10.1007/978-3-319-66200-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-66200-8_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-66199-5

  • Online ISBN: 978-3-319-66200-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation